CancerResource

CancerResource consolidates cancer-relevant compound–target relationships by integrating literature-mined cancer annotations, external databases (Comparative Toxicogenomics Database (CTD), Therapeutic Target Database (TTD), Pharmacogenomics Knowledge Base (PharmGKB), DrugBank), and experimental data to support analysis of gene functions and cellular effects.

Key Features:

• Integration of compound–target relationships: Aggregates compound–target interaction data relevant to cancer from multiple sources into a single repository.
• Literature mining: Extracts cancer-specific annotations and compound–target relationships via developer-conducted literature mining.
• External database incorporation: Incorporates entries from CTD, TTD, PharmGKB, and DrugBank.
• Experimental evidence enrichment: Links interactions to essential experimental data and supporting information on gene functions and cellular effects.
• Combined curated and novel data: Merges curated database entries with literature-mined novel interactions.
• Repository overlap assessment: Assesses and reports the degree of overlap among integrated resources, revealing limited redundancy across CTD, TTD, PharmGKB, and DrugBank.

Scientific Applications:

• Oncology research: Provides consolidated compound–target interaction data to support studies in cancer biology and target identification.
• Exploration of compound–target interactions: Enables researchers to investigate relationships between compounds and targets alongside gene functions and cellular effects.
• Personalized medicine and clinical research: Supports analyses relevant to cancer diagnosis, treatment strategies, and individualized therapeutic approaches.

Methodology:

Developer-conducted literature mining focused on cancer annotations combined with integration of external databases (CTD, TTD, PharmGKB, DrugBank) and incorporation of experimental evidence and supporting gene/cellular effect information.